EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Passive surveillance of human African trypanosomiasis in the Democratic Republic of the Congo: clinical presentation and prospective evaluation of rapid diagnostic and reference laboratory test accuracy

Jacquies Makabuza, Ipos Ngay Lukusa, Crispin Lumbala, Erick Mwamba Miaka, Pathou Nganzobo, Alain Fukinsia, Jean Kwete, Nicolas Bebronne, Philippe Büscher, Dieudonné Mumba Ngoyi, Veerle Lejon iD

PLOS Neglected Tropical Diseases · 29.09.2025 · 19 (9) · e0013045

DOI: 10.1371/journal.pntd.0013045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 29.09.2025. Verfasst von Jacquies Makabuza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Congo. Hauptthemen laut MEDLINE: Trypanosomiasis, African, Diagnostic Tests, Routine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, EDCTP2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Passive screening of gambiense human African trypanosomiasis (HAT) is based on rapid diagnostic tests (RDT), but sensitivity of the currently commercialised RDTs has hardly been assessed prospectively. In view of the increasing importance of remote testing for HAT, the diagnostic performance of reference laboratory tests also needs further documentation. Methodology/Principal Findings The study is registered in ClinicalTrials.Gov under identifier NCT03356665. Clinical suspects in 29 health facilities in DR Congo were screened consecutively between October 2017 and December 2020 with 3 HAT RDTs, including HAT Sero K -SeT, an RDT that is nowadays still commercialised. HAT RDT positives were examined parasitologically and their dried blood spots tested in trypanolysis, indirect ELISA/ T.b. gambiense , LAMP Trypanosoma brucei Detection Kit and m18S and TgsGp qPCR. Association of clinical signs with HAT, and sensitivity, specificity, and predictive values of the screening and reference laboratory tests were estimated using parasitology as the gold standard. Trypanosomes were detected in 42/3113 study participants. Logistic regression revealed that sleep disruption, enlarged lymph nodes, psychiatric problems, recurrent fever not responding to anti-malarials and motor disorders were significantly associated with HAT ( p < 0.05, odds 3.0-10.6). Together, the RDTs detected 253/3113 seropositives. Sensitivity and specificity of HAT Sero K -SeT were respectively 100% (42/42; 95% CI 91.6-100%) and 93.9% (2882/3071; 95% CI 92.9-94.6%). Specificities of the reference laboratory tests were ≥ 91.6%, except for LAMP. Sensitivity of ELISA/ T.b. gambiense and trypanolysis were 93.9% (31/33; 95% CI 80.4-98.9) and 84.9% (28/33; 95% CI 69.1-93.4), and were ≤ 63.6% for LAMP , m18S and TgsGp qPCR. Conclusions/Significance Compared to the WHO’s target product profiles for gambiense HAT RDTs, the HAT Sero K -SeT RDT had ideal sensitivity but its specificity was on the borderline of minimally acceptable. Sub-optimal sensitivities of trypanolysis and to a lesser extent, indirect ELISA/ T.b. gambiense when applied on DBS, were confirmed. Molecular tests for remote testing need to be improved and evaluated further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosomiasis, AfricanDiagnostic Tests, RoutineHumansDemocratic Republic of the CongoMaleFemaleAdultProspective StudiesSensitivity and SpecificityMiddle AgedTrypanosoma brucei gambienseYoung AdultAdolescentAgedChildRapid Diagnostic Tests

Autor:innen und Institutionen

  • Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Congo.
  • Institut National de Recherche Biomédicale, Kinshasa, Congo.
  • Université Officielle de Mbujimayi, Kasai Oriental, Congo.
  • Institute of Tropical Medicine, Antwerpen, Belgium.
  • Institut de Recherche pour le Développement, CIRAD, University of Montpellier, Montpellier, France.

ORCID-Profile: Veerle Lejon

Förderung

  • European Union
  • EDCTP2

Zitieren

APA

Makabuza, J., Lukusa, I. N., Lumbala, C., Miaka, E. M., Nganzobo, P., Fukinsia, A., Kwete, J., Bebronne, N., Büscher, P., Ngoyi, D. M., & Lejon, V. (2025). Passive surveillance of human African trypanosomiasis in the Democratic Republic of the Congo: clinical presentation and prospective evaluation of rapid diagnostic and reference laboratory test accuracy. PLOS Neglected Tropical Diseases, 19(9), e0013045. https://doi.org/10.1371/journal.pntd.0013045

Vancouver

Makabuza J, Lukusa IN, Lumbala C, Miaka EM, Nganzobo P, Fukinsia A, et al. Passive surveillance of human African trypanosomiasis in the Democratic Republic of the Congo: clinical presentation and prospective evaluation of rapid diagnostic and reference laboratory test accuracy. PLOS Neglected Tropical Diseases. 2025;19(9):e0013045. doi:10.1371/journal.pntd.0013045

BibTeX
@article{Makabuza2025,
  author = {Makabuza, Jacquies and Lukusa, Ipos Ngay and Lumbala, Crispin and Miaka, Erick Mwamba and Nganzobo, Pathou and Fukinsia, Alain and Kwete, Jean and Bebronne, Nicolas and Büscher, Philippe and Ngoyi, Dieudonné Mumba and Lejon, Veerle},
  title = {Passive surveillance of human African trypanosomiasis in the Democratic Republic of the Congo: clinical presentation and prospective evaluation of rapid diagnostic and reference laboratory test accuracy},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  volume = {19},
  number = {9},
  pages = {e0013045},
  doi = {10.1371/journal.pntd.0013045}
}
Kostenlos starten →